Science in the City: Nanotech and the development of a 10-minute test for infectious disease

An instrument that gives diagnostic results in less than 10 minutes at the doctor’s office? Researcher Charlie Corredor will be discussing nanotechnology and the development of a system that will allow clinicians to diagnose and treat patients with confidence in a single visit.

Charlie Corredor holds a dual PhD in Chemical Engineering, Nanotechnology and Molecular Engineering from the University of Washington (UW), where he received the prestigious NSF Graduate Research Fellowship and National Academies Ford Graduate Research Fellowship to study the environmental and biological effects of nanotechnology. Currently, Charlie is a co-founder of Phoresa, a Seattle-based and UW-spinout company that focuses on creating low-cost medical devices to improve the diagnosis and treatment of patients with infectious diseases. Charlie is working closely with researchers to develop and evaluate the technology, as well as leading the commercialization of Phoresa’s novel point-of-care diagnostic platform. He also has three US patents, 15 peer-reviewed publications in high impact scientific peer-reviewed journals, and holds a technology and entrepreneurship business graduate certificate from UW-Foster School of Business. Charlie is passionate about innovation, technology transfer, and impacting the world through science and discovery.